), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it will be entering into a ...

NEW YORK, NY--(Marketwired - Mar 24, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells ...

NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“Intellicell”) or the (“Company”), Intellicell has licensed its ...

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences Inc. (“IntelliCell” or the “Company”) today announced that its previously announced merger with Media Exchange Group, Inc. (“MEG”) (OTCQB: CWLCD) has ...

Partners will investigate stromal vascular fraction cells, the basis of IntelliCell’s product. IntelliCell BioSciences inked a sponsored research agreement with the Institute for Cell Engineering and ...

NEW YORK, Oct. 4, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC) announced today that it has been granted a Research Tissue Banking License by the New York State ...

NEW YORK, Oct. 9, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that it has been successful in manufacturing stromal vascular cells from Non-Living adipose ...

NEW YORK--(BUSINESS WIRE)-- IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“IntelliCell”) or the (“Company”), December 27, 2010 IntelliCell filed its patent application with the US ...

IntelliCell BioSciences, Inc. has announced that it has signed an agreement to open an Adipose Stem Cell Processing Center in Denver, Colorado in the next six weeks. This center will make adipose ...

According to Dr. Zain Khalpey's conclusions in the clinical communications to The American Journal of Medicine, "We postulate that the intramyocardial administration of multi-potent adipose-derived ...